losartan has been researched along with bq 123 in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (44.44) | 18.2507 |
| 2000's | 8 (29.63) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuramochi, M | 1 |
| Chen, L; Gopalakrishnan, V; McNeill, JR; Wilson, TW | 1 |
| Funder, JW; Provencher, PH; Saltis, J | 1 |
| Adachi, S; Hirata, Y; Hiroe, M; Ito, H; Koike, A; Murumo, F; Nogami, A; Tanaka, M; Tsujino, M | 1 |
| Leskinen, H; Ruskoaho, H; Vuolteenaho, O | 1 |
| Becker, K; Brodde, OE; Heinroth-Hoffmann, I; Pönicke, K | 1 |
| Chappell, MC; Ferrario, CM; Iyer, SN | 1 |
| Hempelmann, RG; Mehdorn, HM; Pradel, RH; Ziegler, A | 1 |
| Gardner, DG; Liang, F | 1 |
| Hagiwara, Y; Hanada, M; Kambe, T; Kubo, T; Saito, E | 1 |
| Alvarez, BV; Camilión de Hurtado, MC; Cingolani, HE; Ennis, IL | 1 |
| Hagiwara, Y; Ibusuki, T; Kambe, T; Kubo, T; Saito, E | 2 |
| Chiba, S; Fukumori, R; Ibusuki, T; Kambe, T; Kubo, T | 2 |
| Calaghan, SC; White, E | 1 |
| Bkaily, G; Brochu, I; D'Orléans-Juste, P; Labonté, J | 1 |
| Capuano, V; Coulombe, A; Deroubaix, E; Ferron, L; Renaud, JF; Ruchon, Y | 1 |
| Altieri, PI; Crespo, MJ; Escobales, N | 1 |
| Cicha, MZ; Kopp, UC; Smith, LA | 1 |
| Günzel, C; Marx, N; Mischke, K; Noor-Ebad, F; Rana, OR; Saygili, E; Schauerte, P; Schwinger, RH | 1 |
| Boyd, R; Ding, LL; Rätsep, MT; Wang, HD | 1 |
| Dhein, S; Hoyer, A; Kempfert, J; Mohr, FW; Pritzwald-Stegmann, P | 1 |
| Chatsudthipong, V; Kongrat, S; Muanprasat, C; Srisawat, U | 1 |
| Brines, L; Calvo, C; Canto, ID; Chorro, FJ; Soler, C; Such, L; Such-Miquel, L; Tormos, Á; Trapero, I; Zarzoso, M | 1 |
| Konczalla, J; Mrosek, J; Seifert, V; Vatter, H; Wanderer, S | 1 |
| Caballero-George, C; Digman, MA; Gratton, E; Planes, N; Vanderheyden, PPML | 1 |
27 other study(ies) available for losartan and bq 123
| Article | Year |
|---|---|
[New antihypertensive drugs on various phases of study].
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amino Acids; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Diuretics; Humans; Imidazoles; Losartan; Peptides, Cyclic; Receptors, Cell Surface; Receptors, Endothelin; Sulfhydryl Compounds; Tetrazoles | 1992 |
Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Arteries; Biphenyl Compounds; Endothelin Receptor Antagonists; Endothelins; Imidazoles; In Vitro Techniques; Losartan; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Tail; Tetrazoles | 1995 |
Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells.
Topics: Aldosterone; Androstanols; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cells, Cultured; Endothelin Receptor Antagonists; Endothelins; Glucocorticoids; Hypertension; Imidazoles; Losartan; Male; Mifepristone; Muscle, Smooth, Vascular; Peptides, Cyclic; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Tetrazoles; Viper Venoms | 1995 |
Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.
Topics: Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Endothelin Receptor Antagonists; Endothelins; Gene Expression; Imidazoles; In Vitro Techniques; Losartan; Molecular Sequence Data; Muscle Proteins; Myocardium; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Peptides, Cyclic; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles | 1993 |
Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Function, Right; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Volume; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hemodynamics; Hormones; Imidazoles; Losartan; Male; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptides, Cyclic; Plasma Substitutes; Pressure; Protein Precursors; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles | 1997 |
Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells.
Topics: Angiotensin II; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Biphenyl Compounds; Cell Adhesion; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelins; GTP-Binding Proteins; Heart; Imidazoles; Inositol; Inositol Phosphates; Isotope Labeling; Losartan; Myocardium; Peptide Fragments; Peptides, Cyclic; Pertussis Toxin; Phenylalanine; Rats; Rats, Wistar; Tetrazoles; Vasoconstrictor Agents; Virulence Factors, Bordetella | 1997 |
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1998 |
Contractions induced by NO synthase inhibition in isolated rat basilar artery: role of the endothelium and endogenous vasoconstrictors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Arginine Vasopressin; Basilar Artery; Carbachol; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Hormone Antagonists; Indomethacin; Ketanserin; Losartan; Male; Muscarinic Agonists; Nitric Oxide Synthase; Nitroarginine; Norepinephrine; Peptides, Cyclic; Periodicity; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasoconstriction; Vasoconstrictor Agents | 1998 |
Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes.
Topics: Angiotensin II; Animals; Antibodies; Autocrine Communication; Cells, Cultured; Culture Media, Conditioned; Endothelin-1; Gene Expression Regulation; Genes, Reporter; Humans; Losartan; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Paracrine Communication; Peptides, Cyclic; Promoter Regions, Genetic; Rats; RNA, Messenger; Sprains and Strains; Transfection; Transforming Growth Factor beta; Ventricular Function | 1998 |
Evidence that angiotensin II, endothelins and nitric oxide regulate mitogen-activated protein kinase activity in rat aorta.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Peptides, Cyclic; Rats; Rats, Wistar | 1998 |
Stretch-induced alkalinization of feline papillary muscle: an autocrine-paracrine system.
Topics: Alkalies; Alkaloids; Amiloride; Angiotensin II; Animals; Anti-Arrhythmia Agents; Autocrine Communication; Benzophenanthridines; Cats; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Heart; Hydrogen-Ion Concentration; Losartan; Muscle Contraction; Muscle Fibers, Skeletal; Oligopeptides; Papillary Muscles; Paracrine Communication; Peptides, Cyclic; Phenanthridines; Protein Kinase C; Sodium-Hydrogen Exchangers | 1998 |
Vascular mitogen-activated protein kinase activity is enhanced via angiotensin system in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Endothelin-1; Endothelium, Vascular; Enzyme Activation; Hypertension; Losartan; Male; Peptides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1999 |
Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Activation; Hypertension; In Vitro Techniques; Losartan; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Peptides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Endothelin; Sodium Chloride; Vasoconstrictor Agents | 2000 |
Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Glycopeptides; Losartan; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Pepstatins; Peptides, Cyclic; Protease Inhibitors; Protein Precursors; Rats; Rats, Wistar; Renin | 2001 |
Contribution of angiotensin II, endothelin 1 and the endothelium to the slow inotropic response to stretch in ferret papillary muscle.
Topics: Angiotensin II; Animals; Endothelin-1; Endothelium; Female; Ferrets; Kinetics; Losartan; Male; Muscle Spindles; Myocardial Contraction; Octoxynol; Oligopeptides; Papillary Muscles; Peptides, Cyclic; Saralasin | 2001 |
Altered mitogen-activated protein kinase activation in vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Aging; Animals; Aorta, Thoracic; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Genetic Predisposition to Disease; Hypertension; Losartan; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Peptides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2002 |
Role of endothelin receptors in the hypertensive state of kinin B(2) knockout mice subjected to a high-salt diet.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Hypertension; Kidney; Losartan; Male; Mice; Mice, Knockout; Myocardium; Oligopeptides; Peptides, Cyclic; Piperidines; Protein Precursors; Receptor, Bradykinin B2; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Angiotensin; Receptors, Bradykinin; Receptors, Endothelin; RNA, Messenger; Sodium Chloride, Dietary | 2002 |
Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Bosentan; Butadienes; Calcium Channels, T-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Constriction, Pathologic; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Flavonoids; Gene Expression; Losartan; Male; Membrane Potentials; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Nickel; Nitriles; Oligopeptides; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Signal Transduction; Sulfonamides | 2003 |
Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamsters.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Binding, Competitive; Cardiomyopathies; Cricetinae; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin-1; In Vitro Techniques; Losartan; Male; Mesocricetus; Peptides, Cyclic; Protein Binding; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Activation of endothelin-a receptors contributes to angiotensin-induced suppression of renal sensory nerve activation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Dinoprostone; Dose-Response Relationship, Drug; Drug Combinations; Endothelin A Receptor Antagonists; Kidney; Kidney Pelvis; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Peptides, Cyclic; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium, Dietary; Substance P | 2007 |
Irregular electrical activation of intrinsic cardiac adrenergic cells increases catecholamine-synthesizing enzymes.
Topics: Animals; Calcineurin Inhibitors; Catecholamines; Coculture Techniques; Cyclosporine; Dopamine beta-Hydroxylase; Electric Stimulation; Endothelin A Receptor Antagonists; Epinephrine; Losartan; Metoprolol; Myocardium; Myocytes, Cardiac; NFATC Transcription Factors; Peptides, Cyclic; Rats; Signal Transduction; Tacrolimus; Tyrosine 3-Monooxygenase | 2011 |
ETA and ETB receptors are expressed in vascular adventitial fibroblasts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Blotting, Western; Cells, Cultured; Collagen Type I; Connective Tissue; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Losartan; Mice; Oligopeptides; Peptides, Cyclic; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; Time Factors; Viper Venoms | 2011 |
Acute hemodynamic effects of angiotensin- converting enzyme inhibition after prolonged cardiac arrest with Bretschneider's solution.
Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelin Receptor Antagonists; Glucose; Heart Arrest; Hemodynamics; Losartan; Male; Malondialdehyde; Mannitol; Myocardial Reperfusion Injury; Oxygen Consumption; Peptides, Cyclic; Potassium Chloride; Procaine; Rabbits | 2014 |
Losartan and Sodium Nitroprusside Effectively Protect against Renal Impairments after Ischemia and Reperfusion in Rats.
Topics: Adenosine Triphosphatases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Captopril; Ischemia; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Peptides, Cyclic; Rats, Wistar; Renal Insufficiency; Reperfusion; Reperfusion Injury | 2015 |
Experimental Study of the Effects of EIPA, Losartan, and BQ-123 on Electrophysiological Changes Induced by Myocardial Stretch.
Topics: Amiloride; Angiotensin II Type 1 Receptor Blockers; Animals; Endothelin Receptor Antagonists; Epithelial Sodium Channel Blockers; Heart; Losartan; Myocardium; Peptides, Cyclic; Rabbits; Sodium-Hydrogen Exchangers; Stress, Physiological; Ventricular Fibrillation | 2015 |
Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Basilar Artery; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Losartan; Male; Oligopeptides; Peptides, Cyclic; Piperidines; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Subarachnoid Hemorrhage; Vasoconstriction; Vasodilation; Vasospasm, Intracranial | 2018 |
Number and brightness analysis to study spatio-temporal distribution of the angiotensin II AT
Topics: Angiotensin II; Animals; Binding Sites; CHO Cells; Cricetulus; Endothelin-1; Fluorescence Resonance Energy Transfer; Humans; Isoxazoles; Ligands; Losartan; Peptides, Cyclic; Protein Aggregates; Receptor, Endothelin A; Thiophenes | 2019 |